FDA’s Recent COVID-19 Guidances Facilitating Expanded Access to Certain Medical Products
April 14, 2020
On April 14, The Food and Drug Law Institute (FDLI) hosted a free webinar geared towards manufacturers looking to expand their scope to include high-demand medical products, such as ventilators, hand sanitizer, and digital health devices. Chad Landmon, chair of Axinn’s IP and FDA practice groups, joined other leaders in FDA law to share their perspectives on the FDA’s recent COVID-19 guidances and offer practical tips for companies looking to make a switch or to expand their production.
Click here to access the webinar.